Senores Pharmaceuticals Limited (‘Senores’ or ‘SPL’) has officially inaugurated its state-of-the-art greenfield Active Pharmaceutical Ingredient (API) manufacturing facility in Mehsana, Gujarat. Located at Survey No. 1503, Rajpur, Kadi, the sprawling 230,000 sq. ft. plant boasts an installed capacity of approximately 100 Metric Tons per Annum, marking a significant expansion in Senores’ API production capabilities.
This new facility is Senores’ second API manufacturing unit, strategically designed to strengthen its foothold in regulated markets and enhance its offerings in the Contract Development and Manufacturing Organization (CDMO) and Contract Manufacturing Organization (CMO) sectors.
Mr. Swapnil Shah, Managing Director of Senores Pharmaceuticals Limited, expressed his enthusiasm, stating, “We are thrilled to commence operations at our advanced API facility in Mehsana. This expansion will not only broaden our product portfolio but also reinforce our competitiveness in global markets.”
The inauguration of this facility underscores Senores’ commitment to innovation and growth in the pharmaceutical industry, positioning the company as a key player in API manufacturing and CDMO/CMO services.